KPC Pharmaceuticals Inc Cash Flow Quality Index
KPC Pharmaceuticals Inc cash flow quality index. KPC Pharmaceuticals Inc (600422) has a Cash Flow Quality Index of 1.40x as of December 2025. Operating cash flow of CN¥113.07 Million exceeds net income of CN¥80.57 Million, indicating high earnings quality where cash backs reported profits. See financial flexibility index of KPC Pharmaceuticals Inc to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of KPC Pharmaceuticals Inc (1999–2025)
Cash flow quality index of KPC Pharmaceuticals Inc from 1999 to 2025. Historical Cash Flow Quality Index for KPC Pharmaceuticals Inc across 26 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore KPC Pharmaceuticals Inc (600422) cash flow to debt to assess how comfortably operating cash covers total debt obligations.
KPC Pharmaceuticals Inc Cash Flow Quality Index by Year (1999–2025)
KPC Pharmaceuticals Inc cash flow quality index by year from 1999 to 2025. Year-by-year earnings quality comparison for KPC Pharmaceuticals Inc. For the full cash flow conversion analysis, see KPC Pharmaceuticals Inc operating cash flow efficiency.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 0.83x | CN¥289.24 Million | CN¥349.94 Million | ▼ -23.2% |
| 2024 | 1.08x | CN¥808.07 Million | CN¥751.22 Million | ▼ -36.6% |
| 2023 | 1.70x | CN¥754.33 Million | CN¥444.68 Million | ▲ +157.5% |
| 2022 | 0.66x | CN¥253.90 Million | CN¥385.46 Million | ▲ +32.9% |
| 2021 | 0.50x | CN¥251.63 Million | CN¥507.67 Million | ▼ -44.1% |
| 2020 | 0.89x | CN¥409.94 Million | CN¥462.18 Million | ▼ -3.4% |
| 2019 | 0.92x | CN¥429.50 Million | CN¥467.76 Million | ▼ -10.9% |
| 2018 | 1.03x | CN¥352.07 Million | CN¥341.69 Million | ▲ +42.4% |
| 2017 | 0.72x | CN¥242.53 Million | CN¥335.29 Million | ▼ -4.8% |
| 2016 | 0.76x | CN¥311.16 Million | CN¥409.52 Million | ▼ -31.2% |
| 2015 | 1.11x | CN¥476.62 Million | CN¥431.32 Million | ▼ -10.3% |
| 2014 | 1.23x | CN¥379.13 Million | CN¥307.70 Million | ▲ +20.0% |
| 2013 | 1.03x | CN¥241.97 Million | CN¥235.64 Million | ▼ -3.2% |
| 2012 | 1.06x | CN¥213.33 Million | CN¥201.18 Million | ▲ +10.0% |
| 2011 | 0.96x | CN¥140.24 Million | CN¥145.46 Million | ▲ +4.8% |
| 2010 | 0.92x | CN¥90.82 Million | CN¥98.68 Million | ▼ -52.1% |
| 2009 | 1.92x | CN¥128.57 Million | CN¥66.95 Million | ▼ -24.1% |
| 2008 | 2.53x | CN¥91.59 Million | CN¥36.21 Million | ▼ -39.8% |
| 2007 | 4.20x | CN¥130.06 Million | CN¥30.95 Million | ▲ +24.5% |
| 2006 | 3.38x | CN¥61.25 Million | CN¥18.15 Million | ▲ +11943.3% |
| 2004 | -0.03x | CN¥-2.78 Million | CN¥97.47 Million | ▼ -103.8% |
| 2003 | 0.76x | CN¥61.23 Million | CN¥80.74 Million | ▲ +131.6% |
| 2002 | 0.33x | CN¥17.38 Million | CN¥53.09 Million | ▼ -78.0% |
| 2001 | 1.49x | CN¥67.07 Million | CN¥45.03 Million | ▲ +42.2% |
| 2000 | 1.05x | CN¥47.76 Million | CN¥45.58 Million | ▼ -35.6% |
| 1999 | 1.63x | CN¥60.24 Million | CN¥37.01 Million | — |